Swiss WorldCargo has received IATA’s Center for Independent Validators (CEIV) Pharma certification which covers the entire airline and organization.
The certification was awarded following an extensive review from IATA recognised independent auditors. IATA’s director general and CEO, Alexandre de Juniac handed over the certificate to Swiss International Air Lines chief financial officer and member of the management board, Michael Niggemannand head of cargo, Ashwin Bhat (pictured above).
Swiss WorldCargo’s Zurich hub has already received the distinction of being CEIV certified in 2016, and is also recognised as GDP compliant by Swiss authorities Swissmedic.
Bhat said: “Quality, reliability and long-standing experience underscore all our efforts in shipping products around the globe, and we are delighted to have been recognised at not just our hub, but throughout our entire airline and network.
“Our commitment to upholding safety standards throughout our global network offers us opportunities to carry out pharmaceutical shipments around the world. We are happy to play a valuable role in the shipment of pharmaceutical and life-saving products every day.”
De Juniac said: “IATA congratulates Swiss WorldCargo on this important achievement, which demonstrates their commitment to the critical safeguarding of the integrity of pharma products. CEIV Pharma certification ensures these lifesaving products are handled using the best global standards of safety, security, compliance and efficiency.”
Swiss WorldCargo continues to develop a “pharma road-map” to improve its footprint in the important and growing segment of pharmaceuticals and life sciences.
Previously, the carrier was the first company to establish the so-called “quality corridors,” or dedicated pharma traffic lanes between select destinations, that offer safe pharmaceutical shipments from airport to airport.
